Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
9243 | 1105 | 38.5 | 79% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
56 | 28576 | CHOLESTERYL ESTER TRANSFER PROTEIN//JOURNAL OF LIPID RESEARCH//HIGH DENSITY LIPOPROTEIN |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | APOLIPOPROTEIN A5 | Author keyword | 131 | 88% | 6% | 61 |
2 | APOA5 | Author keyword | 91 | 83% | 5% | 52 |
3 | APOLIPOPROTEIN A V | Author keyword | 53 | 79% | 3% | 34 |
4 | APOLIPOPROTEIN C III | Author keyword | 37 | 49% | 5% | 55 |
5 | APOLIPOPROTEIN AV | Author keyword | 31 | 82% | 2% | 18 |
6 | APOLIPOPROTEIN C3 | Author keyword | 23 | 74% | 2% | 17 |
7 | APOLIPOPROTEIN CIII | Author keyword | 22 | 52% | 3% | 30 |
8 | APOA5 GENE | Author keyword | 17 | 100% | 1% | 8 |
9 | APOC3 | Author keyword | 14 | 64% | 1% | 14 |
10 | PREVENT OBES DIABET CARDIOVASC DIS | Address | 10 | 57% | 1% | 12 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | APOLIPOPROTEIN A5 | 131 | 88% | 6% | 61 | Search APOLIPOPROTEIN+A5 | Search APOLIPOPROTEIN+A5 |
2 | APOA5 | 91 | 83% | 5% | 52 | Search APOA5 | Search APOA5 |
3 | APOLIPOPROTEIN A V | 53 | 79% | 3% | 34 | Search APOLIPOPROTEIN+A+V | Search APOLIPOPROTEIN+A+V |
4 | APOLIPOPROTEIN C III | 37 | 49% | 5% | 55 | Search APOLIPOPROTEIN+C+III | Search APOLIPOPROTEIN+C+III |
5 | APOLIPOPROTEIN AV | 31 | 82% | 2% | 18 | Search APOLIPOPROTEIN+AV | Search APOLIPOPROTEIN+AV |
6 | APOLIPOPROTEIN C3 | 23 | 74% | 2% | 17 | Search APOLIPOPROTEIN+C3 | Search APOLIPOPROTEIN+C3 |
7 | APOLIPOPROTEIN CIII | 22 | 52% | 3% | 30 | Search APOLIPOPROTEIN+CIII | Search APOLIPOPROTEIN+CIII |
8 | APOA5 GENE | 17 | 100% | 1% | 8 | Search APOA5+GENE | Search APOA5+GENE |
9 | APOC3 | 14 | 64% | 1% | 14 | Search APOC3 | Search APOC3 |
10 | APOLIPOPROTEINS C | 9 | 83% | 0% | 5 | Search APOLIPOPROTEINS+C | Search APOLIPOPROTEINS+C |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | AV GENE | 120 | 92% | 4% | 47 |
2 | APOA5 GENE | 116 | 92% | 4% | 46 |
3 | CIII | 72 | 60% | 7% | 78 |
4 | PLASMA TRIGLYCERIDE LEVELS | 64 | 62% | 6% | 66 |
5 | APO CIII | 57 | 64% | 5% | 56 |
6 | APOLIPOPROTEIN A5 GENE | 53 | 79% | 3% | 34 |
7 | APOC III | 49 | 66% | 4% | 46 |
8 | APOLIPOPROTEIN A V | 41 | 65% | 4% | 39 |
9 | APOLIPOPROTEIN C III | 39 | 31% | 10% | 105 |
10 | A5 GENE | 38 | 86% | 2% | 19 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The crucial roles of apolipoproteins E and C-III in apoB lipoprotein metabolism in normolipidemia and hypertriglyceridemia | 2015 | 2 | 46 | 61% |
Apolipoprotein CIII Links Dyslipidemia with Atherosclerosis | 2009 | 48 | 39 | 67% |
The paradox of ApoA5 modulation of triglycerides: Evidence from clinical and basic research | 2013 | 9 | 72 | 93% |
Apolipoprotein C-III: understanding an emerging cardiovascular risk factor | 2008 | 81 | 111 | 55% |
Apolipoprotein A-V; a potent triglyceride reducer | 2011 | 25 | 90 | 72% |
Updates on apolipoprotein CIII: fulfilling promise as a therapeutic target for hypertriglyceridemia and cardiovascular disease | 2014 | 8 | 34 | 74% |
Role of ApoCs in lipoprotein metabolism - Functional differences between ApoC1, ApoC2, and ApoC3 | 1999 | 243 | 144 | 47% |
APOA5 and triglyceride metabolism, lesson from human APOA5 deficiency | 2006 | 49 | 40 | 80% |
Apolipoprotein C-III: a potent modulator of hypertriglyceridemia and cardiovascular disease | 2015 | 1 | 75 | 52% |
Apolipoprotein C-III and hepatic triglyceride-rich lipoprotein production | 2012 | 16 | 55 | 44% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PREVENT OBES DIABET CARDIOVASC DIS | 10 | 57% | 1.1% | 12 |
2 | ATHEROSCLEROSIS LIPID METAB | 4 | 75% | 0.3% | 3 |
3 | MED BIOSCI PHYSIOL CHEM | 2 | 23% | 0.8% | 9 |
4 | LIPID LIPOPROT | 2 | 24% | 0.6% | 7 |
5 | BIOMED MASS SPECT UNIT | 2 | 43% | 0.3% | 3 |
6 | UNITAT RECERCA LIPIDS ARTERIOSCLEROSI | 2 | 17% | 0.7% | 8 |
7 | FAMEMA | 1 | 50% | 0.2% | 2 |
8 | CLIN NUTRIGENET NUTRIGENOM | 1 | 16% | 0.5% | 6 |
9 | HLTH SCI FDN | 1 | 40% | 0.2% | 2 |
10 | SECT ENDOCRINOL DIABET HYPERTENS | 1 | 40% | 0.2% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000236588 | APOLIPOPROTEIN B GENE//APOB GENE//SIGNAL PEPTIDE POLYMORPHISM |
2 | 0.0000189178 | APOLIPOPROTEIN A IV//APOA IV//CHILDRENS FDN MEMPHIS |
3 | 0.0000138891 | LIPOPROTEIN GLOMERULOPATHY//APOLIPOPROTEIN E//TYPE III HYPERLIPOPROTEINEMIA |
4 | 0.0000135617 | LIPOPROTEIN LIPASE//GPIHBP1//CHYLOMICRONEMIA |
5 | 0.0000133051 | LIPOPROT UNIT//LIPOPROTEIN KINETICS//OURCE IL KINET ANAL |
6 | 0.0000122247 | CHYLOMICRON REMNANTS//POSTPRANDIAL LIPEMIA//CHYLOMICRON REMNANT |
7 | 0.0000109442 | APOLIPOPROTEIN A I//REVERSE CHOLESTEROL TRANSPORT//APOLIPOPROTEIN A II |
8 | 0.0000097463 | GRADIENT GEL ELECTROPHORESIS//SMALL DENSE LDL//FAMILIAL COMBINED HYPERLIPIDEMIA |
9 | 0.0000092352 | SECT ENDOCRINOL DIABET METAB MC 797//CHOLESTEROL RICH DIETS//APOLIPOPROTEIN E ISOFORMS |
10 | 0.0000085060 | HEPATIC LIPASE//ENDOTHELIAL LIPASE//HEPATIC LIPASE GENE |